Background The role of surgery in treating small cell lung cancer (SCLC) remains
controversial. This meta-analysis aims to determine whether surgical-based treatment …

Background: Early stage small cell lung cancer (T1-2N0M0SCLC) represents 7% of all
SCLC. The standard treatment in patients with intrathoracic SCLC disease is the use of …

Purpose Resection is guideline recommended in stage I small-cell lung cancer (SCLC) but
not in stage II. In this stage, patients are treated with a non-surgical approach. The aim of this …

Background The current National Comprehensive Cancer Network guidelines recommend
surgical treatment for patients with stages I–IIA small cell lung cancer (SCLC), but it still …

The treatment of small cell lung cancer (SCLC) is a challenge for all specialists involved.
New treatments have been added to the therapeutic armamentarium in recent months, but …

Simple Summary Despite guidelines recommending surgery as part of treatment for stage I
small cell lung cancer (SCLC), its application remains inconsistent, and its role in stages II …

There is a lack of predictive models to determine the prognosis of elderly patients diagnosed
with Stage I small-cell lung cancer (SCLC). The purpose of this study was to establish a …

Background: The role of surgery for stage II and III small cell lung cancer (SCLC) remains
controversial. The use of prophylactic cranial irradiation (PCI) for resected SCLC was …

The purpose of this study was to determine the effects of resection coupled with standard
chemotherapy on the survival prognosis of patients with early stage small cell lung …

Background 131 I radioactive iodine therapy (RAI) has been commonly applied for
metastatic differentiated thyroid cancer (DTC) and played an adjunctive role to total …